Nemaura Medical to Ring the Nasdaq Closing Bell
March 06 2018 - 9:00AM
Business Wire
Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology
company developing the wireless sugarBEAT® non-invasive glucose
monitoring system for adjunctive use by persons with diabetes,
today announced that Bashir Timol, Director of Strategy and
Corporate Development, will ring the closing bell of the Nasdaq
Stock Market on Tuesday, March 6, 2018 at 4:00 pm ET.
Mr. Timol will be ringing the bell in honor of the Company’s
recent uplisting to the Nasdaq Capital Market.
A live stream of the Nasdaq Closing Bell will be available
at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
About Nemaura Medical, Inc.
Nemaura Medical Inc. (NASDAQ: NMRD), is a medical technology
company developing sugarBEAT® as a non-invasive, affordable
and flexible glucose monitoring system for adjunctive use by
persons with diabetes. SugarBEAT® consists of a disposable
adhesive skin-patch connected to a rechargeable transmitter, with
an app displaying glucose readings. For more
information, please
visit www.NemauraMedical.com and www.SugarBEAT.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180306005985/en/
Nemaura MedicalBashir TimolDirector of Strategy &
Corporate Developmentbashir.timol@nemauramedical.com
Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
From Apr 2023 to Apr 2024